DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Specialty Active Pharmaceutical Ingredients (API) Market: Global Industry Analysis and Opportunity Assessment, ...

DUBLIN--(BUSINESS WIRE)--The "Active Pharmaceutical Ingredients (APIs) Market - Global Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering. The global active ...

ANÁPOLIS, BR / ACCESS Newswire / December 28, 2025 / Brook S/A, a Brazilian pharmaceutical company led by entrepreneur Wesley ...

Dublin, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The "United States Active Pharmaceutical Ingredients (APIs) Market - Growth, Trends & Forecast 2025-2033" report has been added to ResearchAndMarkets.com's ...

Jan 31 (Reuters) - Teva Pharmaceutical Industries TEVA.TA will divest its active pharmaceutical ingredient (API) unit to focus on its core business, the world's largest generic drugs maker said on ...

NORTH CHICAGO, Ill., Aug. 12, 2025 /PRNewswire/ -- AbbVie (ABBV) today announced a $195 million investment in its North Chicago, Illinois manufacturing plant to expand domestic active pharmaceutical ...

TEL AVIV, Israel--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the appointment of Dr. R. Ananthanarayanan (Ananth) as CEO of its Teva Active ...

U.S. President Donald Trump issued another executive order: "Strategically stockpile the raw materials needed to make ...

The world’s number two producer of active pharmaceutical ingredients (APIs) is for sale. Given the constant global demand for essential medicines, the business might seem like a lucrative asset. But ...

License Agreement grants Sagimet a global, exclusive license to innovative forms of resmetirom active pharmaceutical ingredient (API) developed ...

Melissa Barber ([email protected]), Yale University, New Haven, Connecticut. Reshma Ramachandran, Yale University. Suerie Moon, Geneva Graduate Institute, Geneva, Switzerland. Global supply chains for ...